BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

770 related articles for article (PubMed ID: 22997247)

  • 41. Impact of gonadotropin type on progesterone elevation during ovarian stimulation in GnRH antagonist cycles.
    Lawrenz B; Beligotti F; Engelmann N; Gates D; Fatemi HM
    Hum Reprod; 2016 Nov; 31(11):2554-2560. PubMed ID: 27619773
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Daily low-dose hCG stimulation during the luteal phase combined with GnRHa triggered IVF cycles without exogenous progesterone: a proof of concept trial.
    Andersen CY; Elbaek HO; Alsbjerg B; Laursen RJ; Povlsen BB; Thomsen L; Humaidan P
    Hum Reprod; 2015 Oct; 30(10):2387-95. PubMed ID: 26209535
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Impact of Gonadotropin-Releasing Hormone Agonist Pre-treatment on the Cumulative Live Birth Rate in Infertile Women With Adenomyosis Treated With IVF/ICSI: A Retrospective Cohort Study.
    Chen M; Luo L; Wang Q; Gao J; Chen Y; Zhang Y; Zhou C
    Front Endocrinol (Lausanne); 2020; 11():318. PubMed ID: 32547490
    [No Abstract]   [Full Text] [Related]  

  • 44. The use of gonadotropin-releasing hormone (GnRH) agonist to induce oocyte maturation after cotreatment with GnRH antagonist in high-risk patients undergoing in vitro fertilization prevents the risk of ovarian hyperstimulation syndrome: a prospective randomized controlled study.
    Engmann L; DiLuigi A; Schmidt D; Nulsen J; Maier D; Benadiva C
    Fertil Steril; 2008 Jan; 89(1):84-91. PubMed ID: 17462639
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Combined administration of gonadotropin-releasing hormone agonist with human chorionic gonadotropin for final oocyte maturation in GnRH antagonist cycles for in vitro fertilization.
    Kim CH; Ahn JW; You RM; Kim SH; Chae HD; Kang BM
    J Reprod Med; 2014; 59(1-2):63-8. PubMed ID: 24597289
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Live birth rates following natural cycle IVF in women with poor ovarian response according to the Bologna criteria.
    Polyzos NP; Blockeel C; Verpoest W; De Vos M; Stoop D; Vloeberghs V; Camus M; Devroey P; Tournaye H
    Hum Reprod; 2012 Dec; 27(12):3481-6. PubMed ID: 22940767
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparison of pregnancy outcomes between GnRH antagonist protocol with freeze-all strategy and long-acting GnRH agonist protocol in women with adenomyosis undergoing IVF/ICSI: a propensity-score matching analysis.
    Zhang L; Cai H; Liu X; Xiong Y; Liang X; Shi J
    BMC Pregnancy Childbirth; 2022 Dec; 22(1):946. PubMed ID: 36528566
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Asymptomatic adenomyosis and embryo implantation in IVF cycles.
    Benaglia L; Cardellicchio L; Leonardi M; Faulisi S; Vercellini P; Paffoni A; Somigliana E; Fedele L
    Reprod Biomed Online; 2014 Nov; 29(5):606-11. PubMed ID: 25246118
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Estimating the net effect of progesterone elevation on the day of hCG on live birth rates after IVF: a cohort analysis of 3296 IVF cycles.
    Venetis CA; Kolibianakis EM; Bosdou JK; Lainas GT; Sfontouris IA; Tarlatzis BC; Lainas TG
    Hum Reprod; 2015 Mar; 30(3):684-91. PubMed ID: 25586787
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Administration of corifollitropin alfa on Day 2 versus Day 4 of the cycle in a GnRH antagonist protocol: a randomized controlled pilot study.
    Blockeel C; Polyzos NP; Derksen L; De Brucker M; Vloeberghs V; van de Vijver A; De Vos M; Tournaye H
    Hum Reprod; 2014 Jul; 29(7):1500-7. PubMed ID: 24813196
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Longer ovarian stimulation reduces embryo number and clinical pregnancy rate in long GnRH agonist cycles.
    Dunne C; Lawrence C; Albert A; Havelock JC
    Minerva Ginecol; 2017 Apr; 69(2):135-140. PubMed ID: 27270672
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Natural cycle IVF reduces the risk of low birthweight infants compared with conventional stimulated IVF.
    Mak W; Kondapalli LA; Celia G; Gordon J; DiMattina M; Payson M
    Hum Reprod; 2016 Apr; 31(4):789-94. PubMed ID: 26908846
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A randomized double blind comparison of atosiban in patients undergoing IVF treatment.
    Ng EH; Li RH; Chen L; Lan VT; Tuong HM; Quan S
    Hum Reprod; 2014 Dec; 29(12):2687-94. PubMed ID: 25336707
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Effects of uterine adenomyosis on clinical outcomes of infertility patients treated with in vitro fertilization/intracytoplasmic sperm injection-embryo transfer (IVF/ICSI-ET)].
    Tao T; Chen S; Chen X; Ye D; Xu L; Tian X; Liu Y; Niu J
    Nan Fang Yi Ke Da Xue Xue Bao; 2015 Feb; 35(2):248-51. PubMed ID: 25736122
    [TBL] [Abstract][Full Text] [Related]  

  • 55. In-vitro maturation of oocytes vs in-vitro fertilization with a gonadotropin-releasing hormone antagonist for women with polycystic ovarian syndrome: can superiority be defined?
    Shavit T; Ellenbogen A; Michaeli M; Kartchovsky E; Ruzov O; Shalom-Paz E
    Eur J Obstet Gynecol Reprod Biol; 2014 Aug; 179():46-50. PubMed ID: 24965979
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Three-dimensional ultrasound diagnosis of adenomyosis is not associated with adverse pregnancy outcome following single thawed euploid blastocyst transfer: prospective cohort study.
    Neal S; Morin S; Werner M; Gueye NA; Pirtea P; Patounakis G; Scott R; Goodman L
    Ultrasound Obstet Gynecol; 2020 Oct; 56(4):611-617. PubMed ID: 32349167
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effect of pretreatment with oral contraceptives and progestins on IVF outcomes in women with polycystic ovary syndrome.
    Wei D; Shi Y; Li J; Wang Z; Zhang L; Sun Y; Zhou H; Xu Y; Wu C; Liu L; Wu Q; Zhuang L; Du Y; Li W; Zhang H; Legro RS; Chen ZJ
    Hum Reprod; 2017 Feb; 32(2):354-361. PubMed ID: 27999118
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The effect of delayed initiation of gonadotropin-releasing hormone antagonist in a flexible protocol on in vitro fertilization outcome.
    Tannus S; Weissman A; Boaz M; Horowitz E; Ravhon A; Golan A; Levran D
    Fertil Steril; 2013 Mar; 99(3):725-30. PubMed ID: 23219008
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The duration of pre-ovulatory serum progesterone elevation before hCG administration affects the outcome of IVF/ICSI cycles.
    Huang CC; Lien YR; Chen HF; Chen MJ; Shieh CJ; Yao YL; Chang CH; Chen SU; Yang YS
    Hum Reprod; 2012 Jul; 27(7):2036-45. PubMed ID: 22561057
    [TBL] [Abstract][Full Text] [Related]  

  • 60. High gonadotropin dosage does not affect euploidy and pregnancy rates in IVF PGS cycles with single embryo transfer.
    Barash OO; Hinckley MD; Rosenbluth EM; Ivani KA; Weckstein LN
    Hum Reprod; 2017 Nov; 32(11):2209-2217. PubMed ID: 29040519
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 39.